![](https://www.diabetesnews.com/wp-content/uploads/2013/05/7871-150x128.png)
Both drugs are injectable glucagon-like peptides (amino acids) designed to be used once a week. The company is hoping to submit data from the studies to U.S. regulatory authorities this year seeking marketing approval for the new drug.
Read more
Both drugs are injectable glucagon-like peptides (amino acids) designed to be used once a week. The company is hoping to submit data from the studies to U.S. regulatory authorities this year seeking marketing approval for the new drug.
Read more